Antibody Interactions with the Capsule ofCryptococcus neoformans
Open Access
- 1 June 2000
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 68 (6) , 3642-3650
- https://doi.org/10.1128/iai.68.6.3642-3650.2000
Abstract
Monoclonal antibodies to the encapsulated fungusCryptococcus neoformansproduce different immunofluorescence (IF) patterns after binding to the polysaccharide capsule. To explore the relationship between the IF pattern and the location of antibody binding, two immunoglobulin M (IgM) monoclonal antibodies (MAbs) (12A1 and 13F1) that differ in protective efficacy and IF pattern and one protective IgG1 MAb (2H1) were studied by IF and electron microscopy (EM). FixingC. neoformanscells in lung tissue for EM resulted in significantly better preservation of the capsule than fixing yeast cells in suspension. The localization of MAbs 12A1 and 13F1 by immunogold EM differed depending on whether the MAb was bound to cells in cut tissue sections embedded in plastic or to cells in solution. In cut tissue sections, MAbs 12A1 and 13F1 bound throughout the capsule, whereas in solution both MAbs bound near the capsule surface. To investigate whether antibody binding to theC. neoformanscapsule affected the binding of other primary or secondary reagents, various combinations of MAbs 12A1, 13F1, and 2H1 were studied by direct and indirect IF. The IF pattern and location of binding for MAbs 12A1, 13F1, and 2H1 varied depending on the presence of other capsule-binding MAbs and the method of detection. The results show that (i) binding of MAbs to theC. neoformanspolysaccharide capsule can modify the binding of subsequent primary or secondary antibodies; (ii) the IgM MAbs bind primarily to the outer capsule regions despite the occurrence of their epitopes throughout the capsule; and (iii) MAb 2H1 staining of newly formed buds is reduced, suggesting quantitative or qualitative differences in bud capsule.Keywords
This publication has 30 references indexed in Scilit:
- Scanning electron microscopy of encapsulated and non-encapsulated Cryptococcus neoformans and the effect of glucose on capsular polysaccharide release 1Medical Mycology, 1999
- Epitope Location in the Cryptococcus neoformans Capsule Is a Determinant of Antibody EfficacyThe Journal of Experimental Medicine, 1997
- Cryptococcus neoformans: Paradigm for the Role of Antibody Immunity Against Fungi?Zentralblatt für Bakteriologie, 1996
- Peptide Libraries Define the Fine Specificity of Anti-polysaccharide Antibodies toCryptococcus neoformansJournal of Molecular Biology, 1996
- Epidemiology of Cryptococcosis in France: A 9-Year Survey (1985-1993)Clinical Infectious Diseases, 1996
- J774 Murine Macrophage-like Cell Interactions with Cryptococcus neoformans in the Presence and Absence of OpsoninsThe Journal of Infectious Diseases, 1996
- Molecular characterization of the humoral responses to Cryptococcus neoformans infection and glucuronoxylomannan-tetanus toxoid conjugate immunization.The Journal of Experimental Medicine, 1993
- Ultrastructural study ofCryptococcus neoformans by quick-freezing and deep-etching methodMycopathologia, 1993
- Antibodies Elicited by a Cryptococcus neoformans-Tetanus Toxoid Conjugate Vaccine Have the Same Specificity as Those Elicited in InfectionThe Journal of Infectious Diseases, 1992
- Immunoelectronmicroscopic characterization of monoclonal antibodies (MAbs) against Cryptococcus neoformansMolecular and Cellular Probes, 1989